| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 1,520 | 2,810 | 1,846 | | Cost of Revenue | 2,921 | 3,812 |
-
| | | Gross Profit | (1,401) | (1,002) | 1,846 | | | Operating Expenses | | Research Development | 1,084 | 1,465 | 781 | | Selling General and Administrative | 2,752 | 3,842 | 7,902 | | Non Recurring | 531 | 194 |
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (5,769) | (6,502) | (6,837) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (27) | (348) | (230) | | Earnings Before Interest And Taxes | (5,795) | (6,850) | (7,067) | | Interest Expense | 1,565 | 1,915 | 1,656 | | Income Before Tax | (7,360) | (8,765) | (8,723) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (7,360) | (8,765) | (8,723) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| (31) | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (7,360) | (8,765) | (8,754) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($7,360) | ($8,765) | ($8,754) |
|
0.11% Nasdaq 
0.025 (4.81%) 
Income Statement
